The whole-genome landscape of medulloblastoma subtypes

Nature

Volumn 547, Issue 7663, 2017, Pages 311-317

  Northcott, Paul A ^a,b   Buchhalter, Ivo ^a,c   Morrissy, A Sorana ^d   Hovestadt, Volker ^a   Weischenfeldt, Joachim ^e   Ehrenberger, Tobias ^f   Gröbner, Susanne ^a   Segura Wang, Maia ^h   Zichner, Thomas ^g   Rudneva, Vasilisa A ^b,g   Warnatz, Hans Jörg ^h   Sidiropoulos, Nikos ^e   Phillips, Aaron H ^b   Schumacher, Steven ⁱ   Kleinheinz, Kortine ^a   Waszak, Sebastian M ^g   Erkek, Serap ^a,g   Jones, David T W ^a   Worst, Barbara C ^a   Kool, Marcel ^a   Zapatka, Marc ^a   Jäger, Natalie ^a   Chavez, Lukas ^a   Hutter, Barbara ^a   Bieg, Matthias ^a   Paramasivam, Nagarajan ^a,j   Heinold, Michael ^a,c   Gu, Zuguang ^a   Ishaque, Naveed ^a   Jäger Schmidt, Christina ^a   Imbusch, Charles D ^a   Jugold, Alke ^a   Hübschmann, Daniel ^a,c,k   Risch, Thomas ^h   Amstislavskiy, Vyacheslav ^h   Gonzalez, Francisco German Rodriguez ^e   Weber, Ursula D ^a   Wolf, Stephan ^a   Robinson, Giles W ^a   Zhou, Xin ^b   Wu, Gang ^b   Finkelstein, David ^b   Liu, Yanling ^b   Cavalli, Florence M G ^d   Luu, Betty ^d   Ramaswamy, Vijay ^d   Wu, Xiaochong ^d   Koster, Jan ^l   Ryzhova, Marina ^m   Cho, Yoon Jae ⁿ   Pomeroy, Scott L ^o   Herold Mende, Christel ^c   Schuhmann, Martin ^p   Ebinger, Martin ^p   Liau, Linda M ^q   Mora, Jaume ^r   McLendon, Roger E ^s   Jabado, Nada ^t   Kumabe, Toshihiro ^u   Chuah, Eric ^v   Ma, Yussanne ^v   Moore, Richard A ^v   Mungall, Andrew J ^v   Mungall, Karen L ^v   Thiessen, Nina ^v   Tse, Kane ^v   Wong, Tina ^v   Jones, Steven J M ^v   Witt, Olaf ^k   Milde, Till ^k   Von Deimling, Andreas ^k   Capper, David ^k   Korshunov, Andrey ^k   Yaspo, Marie Laure ^h   Kriwacki, Richard ^b   Gajjar, Amar ^b   Zhang, Jinghui ^b   Beroukhim, Rameen ⁱ   Fraenkel, Ernest ^f   Korbel, Jan O ^g   Brors, Benedikt ^a   Schlesner, Matthias ^a   Eils, Roland ^a,c   Marra, Marco A ^v   Pfister, Stefan M ^a,k   Taylor, Michael D ^d   Lichter, Peter ^a   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f Massachusetts Institute of Technology Cambridge   (United States)

^g EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^h MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

ⁱ BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^j UNIVERSITY OF HEIDELBERG   (Germany)

^k UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^l ACADEMIC MEDICAL CENTER   (Netherlands)

^m BURDENKO NEUROSURGICAL INSTITUTE   (Russian Federation)

ⁿ OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^o HARVARD MEDICAL SCHOOL   (United States)

^p UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^q UNIVERSITY OF CALIFORNIA   (United States)

^r HOSPITAL SANT JOAN DE DÉU   (Spain)

^s DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t MCGILL UNIVERSITY   (Canada)

^u KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^v BRITISH COLUMBIA CANCER AGENCY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRG1 PROTEIN; EPHRIN RECEPTOR A7; ISOCITRATE DEHYDROGENASE 1; PROTEIN PATCHED 1; RETINOBLASTOMA BINDING PROTEIN 2; CARRIER PROTEIN; KBTBD4 PROTEIN, HUMAN; MUSCLE PROTEIN; PRDM6 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; WNT PROTEIN;

BRAIN; CANCER; GENE; GENETIC ANALYSIS; GENOME; GENOMICS; HETEROGENEITY; MUTATION; TUMOR;

ADOLESCENT; ADULT; ARID2 GENE; ARTICLE; CANCER GENETICS; CANCER PATIENT; CARCINOGENESIS; CHILD; CONTROLLED STUDY; CSNK2B GENE; CTNNB1 GENE; DDX3X GENE; ENHANCER REGION; EPIGENETICS; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; GENE INSERTION; GENETIC HETEROGENEITY; HUMAN; INFANT; KBTBD4 GENE; KMT2D GENE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MUTATIONAL ANALYSIS; PRDM6 GENE; PRIORITY JOURNAL; SOMATIC MUTATION; TUMOR GENE; WHOLE GENOME SEQUENCING; CLASSIFICATION; COHORT ANALYSIS; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; EPISTASIS; GENETICS; GENOMICS; HUMAN GENOME; INFORMATION PROCESSING; MOLECULARLY TARGETED THERAPY; MUTATION; ONCOGENE;

CARCINOGENESIS; CARRIER PROTEINS; COHORT STUDIES; DATASETS AS TOPIC; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; EPISTASIS, GENETIC; GENOME, HUMAN; GENOMICS; HUMANS; MEDULLOBLASTOMA; MOLECULAR TARGETED THERAPY; MUSCLE PROTEINS; MUTATION; ONCOGENES; TRANSCRIPTION FACTORS; WHOLE GENOME SEQUENCING; WNT PROTEINS;

EID: 85025159196     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature22973     Document Type: Article

References (65)

1. Kandoth, C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333-339 (2013).
2. Tamborero, D. et al. Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci. Rep. 3, 2650 (2013).
3. Jones, D. T. et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat. Genet. 45, 927-932 (2013).
4. Lee, R. S. et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J. Clin. Invest. 122, 2983-2988 (2012).
5. Jones, D. T. et al. Dissecting the genomic complexity underlying medulloblastoma. Nature 488, 100-105 (2012).
6. Kool, M. et al. Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. Cancer Cell 25, 393-405 (2014).
7. Northcott, P. A. et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 511, 428-434 (2014).
8. Rausch, T. et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations. Cell 148, 59-71 (2012).
9. Robinson, G. et al. Novel mutations target distinct subgroups of medulloblastoma. Nature 488, 43-48 (2012).
10. Morrissy, A. S. et al. Divergent clonal selection dominates medulloblastoma at recurrence. Nature 529, 351-357 (2016).
11. Northcott, P. A. et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488, 49-56 (2012).
12. Northcott, P. A. et al. Medulloblastomics: the end of the beginning. Nat. Rev. Cancer 12, 818-834 (2012).
13. Taylor, M. D. et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 123, 465-472 (2012).
14. Pugh, T. J. et al. Medulloblastoma exome sequencing uncovers subtypespecific somatic mutations. Nature 488, 106-110 (2012).
15. Hovestadt, V. et al. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol. 125, 913-916 (2013).
16. Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415-421 (2013).
17. Decker, B. et al. Biallelic BRCA2 mutations shape the somatic mutational landscape of aggressive prostate tumors. Am. J. Hum. Genet. 98, 818-829 (2016).
18. The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330-337 (2012).
19. Kandoth, C. et al. Integrated genomic characterization of endometrial carcinoma. Nature 497, 67-73 (2013).
20. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218 (2013).
21. Dees, N. D. et al. MuSiC: identifying mutational significance in cancer genomes. Genome Res. 22, 1589-1598 (2012).
22. Gonzalez-Perez, A. et al. IntOGen-mutations identifies cancer drivers across tumor types. Nat. Methods 10, 1081-1082 (2013).
23. Northcott, P. A. et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat. Genet. 41, 465-472 (2009).
24. Parsons, D. W. et al. The genetic landscape of the childhood cancer medulloblastoma. Science 331, 435-439 (2011).
25. Mori, T. et al. Germ-line and somatic mutations of the APC gene in patients with Turcot syndrome and analysis of APC mutations in brain tumors. Genes Chromosom. Cancer 9, 168-172 (1994).
26. Wilson, B. G. et al. Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell 18, 316-328 (2010).
27. Noushmehr, H. et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17, 510-522 (2010).
28. Ceccarelli, M. et al. Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse Glioma. Cell 164, 550-563 (2016).
29. Snuderl, M. et al. Deep sequencing identifies IDH1 R132S mutation in adult medulloblastoma. J. Clin. Oncol. 33, e27-e31 (2015).
30. Fan, X. et al. Notch1 and Notch2 have opposite effects on embryonal brain tumor growth. Cancer Res. 64, 7787-7793 (2004).
31. Garzia, L. et al. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS One 4, e4998 (2009).
32. Lin, C. Y. et al. Active medulloblastoma enhancers reveal subgroup-specific cellular origins. Nature 530, 57-62 (2016).
33. Cho, Y. J. et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J. Clin. Oncol. 29, 1424-1430 (2011).
34. Kool, M. et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 3, e3088 (2008).
35. Northcott, P. A. et al. Medulloblastoma comprises four distinct molecular variants. J. Clin. Oncol. 29, 1408-1414 (2011).
36. Canning, P. et al. Structural basis for Cul3 protein assembly with the BTB-Kelch family of E3 ubiquitin ligases. J. Biol. Chem. 288, 7803-7814 (2013).
37. Weischenfeldt, J. et al. Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking. Nat. Genet. 49, 65-74 (2017).
38. Davis, C. A. et al. PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells. Mol. Cell. Biol. 26, 2626-2636 (2006).
39. Louis, D. N. et al. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol. 131, 803-820 (2016).
40. Shih, D. J. et al. Cytogenetic prognostication within medulloblastoma subgroups. J. Clin. Oncol. 32, 886-896 (2014).
41. Stein, L. D., Knoppers, B. M., Campbell, P., Getz, G. & Korbel, J. O. Data analysis: Create a cloud commons. Nature 523, 149-151 (2015).
42. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
43. Wang, K., Li, M. & Hakonarson, H. AnOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
44. Rimmer, A. et al. Integrating mapping-, assembly-and haplotype-based approaches for calling variants in clinical sequencing applications. Nat. Genet. 46, 912-918 (2014).
45. Alioto, T. S. et al. A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing. Nat. Commun. 6, 10001 (2015).
46. Rausch, T. et al. DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics 28, i333-i339 (2012).
47. Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308-311 (2001).
48. Howie, B. N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
49. Olshen, A. B. et al. Parent-specific copy number in paired tumor-normal studies using circular binary segmentation. Bioinformatics 27, 2038-2046 (2011).
50. Johann, P. D. et al. Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes. Cancer Cell 29, 379-393 (2016).
51. Mermel, C. H. et al. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 12, R41 (2011).
52. Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. Cell Reports 3, 246-259 (2013).
53. Aryee, M. J. et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30, 1363-1369 (2014).
54. Dixon, J. R. et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485, 376-380 (2012).
55. Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).
56. Ongen, H., Buil, A., Brown, A. A., Dermitzakis, E. T. & Delaneau, O. Fast and efficient QTL mapper for thousands of molecular phenotypes. Bioinformatics 32, 1479-1485 (2015).
57. Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
58. Tuncbag, N. et al. Network-Based interpretation of diverse high-throughput datasets through the Omics Integrator software package. PLOS Comput. Biol. 12, e1004879 (2016).
59. Razick, S., Magklaras, G. & Donaldson, I. M. iRefIndex: a consolidated protein interaction database with provenance. BMC Bioinformatics 9, 405 (2008).
60. Wishart, D. S. et al. HMDB 3.0 - The Human Metabolome Database in 2013. Nucleic Acids Res. 41, D801-D807 (2013).
61. Thiele, I. et al. A community-driven global reconstruction of human metabolism. Nat. Biotechnol. 31, 419-425 (2013).
62. Cline, M. S. et al. Integration of biological networks and gene expression data using Cytoscape. Nat. Protocols 2, 2366-2382 (2007).
63. Leiserson, M. D., Wu, H. T., Vandin, F. & Raphael, B. J. CoMEt: a statistical approach to identify combinations of mutually exclusive alterations in cancer. Genome Biol. 16, 160 (2015).
64. Biasini, M. et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 42, W252-W258 (2014).
65. Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15-21 (2013).